NCT01924793 arm group 189da8cdc4de72750c82b08f6ee391be [clinicaltrials_resource:NCT01924793/arm-group/189da8cdc4de72750c82b08f6ee391be]
DAS181-F02 Nebulized Formulation Inhaled Dose [clinicaltrials_resource:12a2cd6cec43ecfbadcbecd5717dcfb7]An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection [clinicaltrials:NCT01924793]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01924793 arm group 189da8cdc4de72750c82b08f6ee391be [clinicaltrials_resource:NCT01924793/arm-group/189da8cdc4de72750c82b08f6ee391be]
Bio2RDF identifier
NCT01924793/arm-group/189da8cdc4de72750c82b08f6ee391be
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 9da8cdc4de72750c82b08f6ee391be
description [clinicaltrials_vocabulary:description]
Subjects unable to use the Dry ...... in the Study Reference Manual.
identifier
clinicaltrials_resource:NCT01924793/arm-group/189da8cdc4de72750c82b08f6ee391be
title
NCT01924793 arm group 189da8cdc4de72750c82b08f6ee391be
@en
type
label
NCT01924793 arm group 189da8cd ...... da8cdc4de72750c82b08f6ee391be]
@en